Pasar al contenido principal

PERFIL DE INTERACCION DE NCS-1 ( NEURONAL CALCIUM SENSOR-1) Y SU IMPLICACION EN ENFERMEDADES DEL NEURODESARROLLO

PID2019-106608RB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO RAMON Y CAJAL

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The inhibition of NCS-1 binding to Ric8a rescues fragile X syndrome mice model phenotypes

  • Cogram, Patricia
  • Fernández-Beltrán, Luis C.
  • Casarejos, María José
  • Sánchez-Yepes, Sonia
  • Rodríguez-Martín, Eulalia
  • García-Rubia, Alfonso
  • Sánchez-Barrena, María José
  • Gil, Carmen
  • Martínez Gil, Ana
  • Mansilla, Alicia
15 p.-6 fig., Fragile X syndrome (FXS) is caused by the loss of function of Fragile X mental retardation protein (FMRP). FXS is one of the leading monogenic causes of intellectual disability (ID) and autism. Although it is caused by the failure of a single gene, FMRP that functions as an RNA binding protein affects a large number of genes secondarily. All these genes represent hundreds of potential targets and different mechanisms that account for multiple pathological features, thereby hampering the search for effective treatments. In this scenario, it seems desirable to reorient therapies toward more general approaches. Neuronal calcium sensor 1 (NCS-1), through its interaction with the guanine-exchange factor Ric8a, regulates the number of synapses and the probability of the release of a neurotransmitter, the two neuronal features that are altered in FXS and other neurodevelopmental disorders. Inhibitors of the NCS-1/Ric8a complex have been shown to be effective in restoring abnormally high synapse numbers as well as improving associative learning in FMRP mutant flies. Here, we demonstrate that phenothiazine FD44, an NCS-1/Ric8a inhibitor, has strong inhibition ability in situ and sufficient bioavailability in the mouse brain. More importantly, administration of FD44 to two different FXS mouse models restores well-known FXS phenotypes, such as hyperactivity, associative learning, aggressive behavior, stereotype, or impaired social approach. It has been suggested that dopamine (DA) may play a relevant role in the behavior and in neurodevelopmental disorders in general. We have measured DA and its metabolites in different brain regions, finding a higher metabolic rate in the limbic area, which is also restored with FD44 treatment. Therefore, in addition to confirming that the NCS-1/Ric8a complex is an excellent therapeutic target, we demonstrate the rescue effect of its inhibitor on the behavior of cognitive and autistic FXS mice and show DA metabolism as a FXS biochemical disease marker., This work was supported by the Caixa Research foundation (Caixa Impulse program CI18-00026) from Spain, the Fragile X Research Foundation from USA and the Spanish Ministerio de Ciencia e Innovación (PID2019-106608RB-I00), and the Instituto de Salud Carlos III (CIBERNED, CB18/05/00040). AlM is funded with the Ramon y Cajal program from The Spanish Ministerio de Ciencia e Innovación (RYC-2017-22392)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The neuronal calcium sensor NCS-1 regulates the phosphorylation state and activity of the Gα chaperone and GEF Ric-8A

  • Muñoz-Reyes, Daniel
  • McClelland, Levi J.
  • Arroyo-Urea, Sandra
  • Sánchez-Yepes, Sonia
  • Sabín, Juan
  • Pérez-Suárez, Sara
  • Menéndez, Margarita
  • Mansilla, Alicia
  • García-Nafría, Javier
  • Sprang, Stephen
  • Sánchez-Barrena, María José
36 pags., 8 figs.,, The neuronal calcium sensor 1 (NCS-1), an EF-hand Ca2+ binding protein, and Ric-8A coregulate synapse number and probability of neurotransmitter release. Recently, the structures of Ric-8A bound to Gα have revealed how Ric-8A phosphorylation promotes Gα recognition and activity as a chaperone and guanine nucleotide exchange factor. However, the molecular mechanism by which NCS-1 regulates Ric-8A activity and its interaction with Gα subunits is not well understood. Given the interest in the NCS-1/Ric-8A complex as a therapeutic target in nervous system disorders, it is necessary to shed light on this molecular mechanism of action at atomic level. We have reconstituted NCS-1/Ric-8A complexes to conduct a multimodal approach and determine the sequence of Ca2+ signals and phosphorylation events that promote the interaction of Ric-8A with Gα. Our data show that the binding of NCS-1 and Gα to Ric-8A are mutually exclusive. Importantly, NCS-1 induces a structural rearrangement in Ric-8A that traps the protein in a conformational state that is inaccessible to casein kinase II-mediated phosphorylation, demonstrating one aspect of its negative regulation of Ric-8A-mediated G-protein signaling. Functional experiments indicate a loss of Ric-8A guanine nucleotide exchange factor (GEF) activity toward Gα when complexed with NCS-1, and restoration of nucleotide exchange activity upon increasing Ca2+ concentration. Finally, the high-resolution crystallographic data reported here define the NCS-1/Ric-8A interface and will allow the development of therapeutic synapse function regulators with improved activity and selectivity., Spanish National Plan for Scientific and Technical Research and Innovation PID2019-111737RB-I00 Maria Jose Sanchez-Barrena Spanish National Plan for Scientific and Technical Research and Innovation PID2019-106608RB-I00 Alicia Mansilla Spanish National Plan for Scientific and Technical Research and Innovation PDC2022-133775-I00 Alicia Mansilla Spanish National Plan for Scientific and Technical Research and Innovation RTI2018-099985-B-I00 Margarita Menendez; Spanish National Plan for Scientific and Technical Research and Innovation PID2020-113359GA-I00 Javier García-Nafría; Spanish National Plan for Scientific and Technical Research and Innovation RYC-2017-22392 Alicia Mansilla; Spanish National Plan for Scientific and Technical Research and Innovation RYC2018-025731-I Javier García-Nafría National Institutes of Health P30GM140963 Stephen Sprang National Institutes of Health R01GM105993 Stephen Sprang, Peer reviewed